291 related articles for article (PubMed ID: 24675078)
1. Increased glucose metabolism and glycerolipid formation by fatty acids and GPR40 receptor signaling underlies the fatty acid potentiation of insulin secretion.
El-Azzouny M; Evans CR; Treutelaar MK; Kennedy RT; Burant CF
J Biol Chem; 2014 May; 289(19):13575-88. PubMed ID: 24675078
[TBL] [Abstract][Full Text] [Related]
2. Diminished acyl-CoA synthetase isoform 4 activity in INS 832/13 cells reduces cellular epoxyeicosatrienoic acid levels and results in impaired glucose-stimulated insulin secretion.
Klett EL; Chen S; Edin ML; Li LO; Ilkayeva O; Zeldin DC; Newgard CB; Coleman RA
J Biol Chem; 2013 Jul; 288(30):21618-29. PubMed ID: 23766516
[TBL] [Abstract][Full Text] [Related]
3. Deletion of GPR40 impairs glucose-induced insulin secretion in vivo in mice without affecting intracellular fuel metabolism in islets.
Alquier T; Peyot ML; Latour MG; Kebede M; Sorensen CM; Gesta S; Ronald Kahn C; Smith RD; Jetton TL; Metz TO; Prentki M; Poitout V
Diabetes; 2009 Nov; 58(11):2607-15. PubMed ID: 19720802
[TBL] [Abstract][Full Text] [Related]
4. The fatty acid receptor GPR40 plays a role in insulin secretion in vivo after high-fat feeding.
Kebede M; Alquier T; Latour MG; Semache M; Tremblay C; Poitout V
Diabetes; 2008 Sep; 57(9):2432-7. PubMed ID: 18559658
[TBL] [Abstract][Full Text] [Related]
5. Free fatty acid receptor 1 (FFAR1/GPR40) signaling affects insulin secretion by enhancing mitochondrial respiration during palmitate exposure.
Kristinsson H; Bergsten P; Sargsyan E
Biochim Biophys Acta; 2015 Dec; 1853(12):3248-57. PubMed ID: 26408932
[TBL] [Abstract][Full Text] [Related]
6. Metabolome response to glucose in the β-cell line INS-1 832/13.
Lorenz MA; El Azzouny MA; Kennedy RT; Burant CF
J Biol Chem; 2013 Apr; 288(15):10923-35. PubMed ID: 23426361
[TBL] [Abstract][Full Text] [Related]
7. Point mutation of Ffar1 abrogates fatty acid-dependent insulin secretion, but protects against HFD-induced glucose intolerance.
Sabrautzki S; Kaiser G; Przemeck GKH; Gerst F; Lorza-Gil E; Panse M; Sartorius T; Hoene M; Marschall S; Häring HU; Hrabě de Angelis M; Ullrich S
Mol Metab; 2017 Oct; 6(10):1304-1312. PubMed ID: 29031729
[TBL] [Abstract][Full Text] [Related]
8. Identification of a mammalian glycerol-3-phosphate phosphatase: Role in metabolism and signaling in pancreatic β-cells and hepatocytes.
Mugabo Y; Zhao S; Seifried A; Gezzar S; Al-Mass A; Zhang D; Lamontagne J; Attane C; Poursharifi P; Iglesias J; Joly E; Peyot ML; Gohla A; Madiraju SR; Prentki M
Proc Natl Acad Sci U S A; 2016 Jan; 113(4):E430-9. PubMed ID: 26755581
[TBL] [Abstract][Full Text] [Related]
9. Alteration of the glucagon axis in GPR120 (FFAR4) knockout mice: a role for GPR120 in glucagon secretion.
Suckow AT; Polidori D; Yan W; Chon S; Ma JY; Leonard J; Briscoe CP
J Biol Chem; 2014 May; 289(22):15751-63. PubMed ID: 24742677
[TBL] [Abstract][Full Text] [Related]
10. Chronic suppression of acetyl-CoA carboxylase 1 in beta-cells impairs insulin secretion via inhibition of glucose rather than lipid metabolism.
Ronnebaum SM; Joseph JW; Ilkayeva O; Burgess SC; Lu D; Becker TC; Sherry AD; Newgard CB
J Biol Chem; 2008 May; 283(21):14248-56. PubMed ID: 18381287
[TBL] [Abstract][Full Text] [Related]
11. Activation of extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) by free fatty acid receptor 1 (FFAR1/GPR40) protects from palmitate-induced beta cell death, but plays no role in insulin secretion.
Panse M; Gerst F; Kaiser G; Teutsch CA; Dölker R; Wagner R; Häring HU; Ullrich S
Cell Physiol Biochem; 2015; 35(4):1537-45. PubMed ID: 25792236
[TBL] [Abstract][Full Text] [Related]
12. Free fatty acids increase cytosolic free calcium and stimulate insulin secretion from beta-cells through activation of GPR40.
Schnell S; Schaefer M; Schöfl C
Mol Cell Endocrinol; 2007 Jan; 263(1-2):173-80. PubMed ID: 17101212
[TBL] [Abstract][Full Text] [Related]
13. The P21-activated kinase PAK4 is implicated in fatty-acid potentiation of insulin secretion downstream of free fatty acid receptor 1.
Bergeron V; Ghislain J; Poitout V
Islets; 2016 Nov; 8(6):157-164. PubMed ID: 27700527
[TBL] [Abstract][Full Text] [Related]
14. Long-term in vitro treatment of INS-1 rat pancreatic β-cells by unsaturated free fatty acids protects cells against gluco- and lipotoxicities via activation of GPR40 receptors.
Tuo Y; Feng DD; Wang DF; Sun J; Li SB; Chen C
Clin Exp Pharmacol Physiol; 2012 May; 39(5):423-8. PubMed ID: 22332921
[TBL] [Abstract][Full Text] [Related]
15. Protective role of Pollen Typhae total flavone against the palmitic acid-induced impairment of glucose-stimulated insulin secretion involving GPR40 signaling in INS-1 cells.
Feng XT; Duan HM; Li SL
Int J Mol Med; 2017 Sep; 40(3):922-930. PubMed ID: 28731171
[TBL] [Abstract][Full Text] [Related]
16. Facilitation of fatty acid uptake by CD36 in insulin-producing cells reduces fatty-acid-induced insulin secretion and glucose regulation of fatty acid oxidation.
Wallin T; Ma Z; Ogata H; Jørgensen IH; Iezzi M; Wang H; Wollheim CB; Björklund A
Biochim Biophys Acta; 2010 Feb; 1801(2):191-7. PubMed ID: 19931418
[TBL] [Abstract][Full Text] [Related]
17. Metabolic fate of glucose and candidate signaling and excess-fuel detoxification pathways in pancreatic β-cells.
Mugabo Y; Zhao S; Lamontagne J; Al-Mass A; Peyot ML; Corkey BE; Joly E; Madiraju SRM; Prentki M
J Biol Chem; 2017 May; 292(18):7407-7422. PubMed ID: 28280244
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of Glucose-stimulated Insulin Secretion by the GPR40-PLC-TRPC Pathway in Pancreatic β-Cells.
Yamada H; Yoshida M; Ito K; Dezaki K; Yada T; Ishikawa SE; Kakei M
Sci Rep; 2016 May; 6():25912. PubMed ID: 27180622
[TBL] [Abstract][Full Text] [Related]
19. β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1.
Mancini AD; Bertrand G; Vivot K; Carpentier É; Tremblay C; Ghislain J; Bouvier M; Poitout V
J Biol Chem; 2015 Aug; 290(34):21131-21140. PubMed ID: 26157145
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules.
Briscoe CP; Peat AJ; McKeown SC; Corbett DF; Goetz AS; Littleton TR; McCoy DC; Kenakin TP; Andrews JL; Ammala C; Fornwald JA; Ignar DM; Jenkinson S
Br J Pharmacol; 2006 Jul; 148(5):619-28. PubMed ID: 16702987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
